Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Capital/Financing Update 2019

Apr 2, 2019

61176_rns_2019-04-02_84670b31-7e2b-46e7-a17d-c8fc04ede246.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

National Stock ExchangeofIndiaLimited,ExchangePlaza,Bandra- Kurla Complex,Bandra (East),Mumbai-400 051 Bombay Stock Exchange Limited,PJTower, DalalStreet,Mumbai 400 001
Sl.No. Particulars Information
1. Amount andpercentageoftheturnoverorrevenue or income andnetworthcontributedbysuchunit/divisionofthe listedentityduring thelast financialyear Inter-segmentrevenue fromthe said undertakingduringFY18-19 wasINR40Cr(Not materialasa%ofturnoverornetworth)
2. Dateonwhich the agreementforsalehasbeen entered into Approval by BoardofDirectorsofthe CompanyprovidedonApril1, 2019
3. Expected dateofcompletionofsale/disposal April1, 2019
4. Consideration receivedfromsuchsale/disposal INR.33.34 Crores

==> picture [146 x 38] intentionally omitted <==